Study of Glecaprevir/Pibrentasvir to Assess Safety Through Real-World Data

Clinical trial NCT07419347 · RECRUITING

Trial details

NCT number: NCT07419347
Sponsor: AbbVie
Status: RECRUITING
Study type: OBSERVATIONAL

Hepatitis C Virus (HCV)

Start date: 2026-02-27
Primary completion: 2026-06-01
Enrollment: 2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.